home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Genetic News | search  
 

Cartilage Sponge-Like Quality Underlies Arthritis Joint Specificity

 
  March, 18 2002 9:19
your information resource in human molecular genetics
 
     
Cartilage has been found to act as a molecular sponge that can absorb blood-borne molecules, which are then targeted by pathogenic antibodies. Two reports in the April issue of Nature Immunology show that joint cartilage is a passive surface that absorbs proteins from the bloodstream. Cartilage lacks the normal cellular controls to prevent antibody-triggered immune attacks. Its unique surface properties help to explain the tissue-specificity of arthritic disease.

In a mouse model of arthritis and in some arthritis patients, pathogenic autoantibodies develop to the ubiquitous enzyme glucose-6-phosphate isomerase (GPI). Why the immune system only attacks joints has been a mystery. Benoist and colleagues show that nothing is unusual about GPI expression in the joint, however GPI from the bloodstream selectively settles on the joint’s articular surfaces. This exposed GPI serves as the target for the pathogenic autoantibodies of arthritic patients. In a second report, Wipke et al. show rapid (within minutes) deposition of anti-GPI in joints of mice infused with these pathogenic antibodies. This latter report confirms the Benoist paper in that even normal joints are coated with GPI. Benoist’s group identifies the second key to joint specificity: the inability of this tissue to regulate the activation of the inflammatory proteins called complement. Their activation on antibody-coated surfaces initiate a cascade of inflammatory responses – a good thing if there’s an infection, but deleterious to the health of a joint.

Author contacts:
Christophe Benoist
Joslin Diabetes Center
Harvard Medical School, Boston
MA, USA
Tel: +1 617 264 2742
E-mail: cb@joslin.harvard.edu

Paul Allen
Department of Pathology
Washington University School of Medicine
St. Louis, MO, USA
Tel: +1 314 362 8758
E-mail: allen@pathbox.wustl.edu

Additional contact for comment on both papers:

Toshio Hirano
Dept of Molecular Oncology
Graduate School of Medicine
Osaka University, Japan
Tel: +81 6 6879 3880
E-mail: hirano@molonc.med.osaka-u.ac.jp

(C) Nature Immunology press release.


Message posted by: Trevor M. D'Souza

print this article mail this article
Bookmark and Share this page (what is this?)

Social bookmarking allows users to save and categorise a personal collection of bookmarks and share them with others. This is different to using your own browser bookmarks which are available using the menus within your web browser.

Use the links below to share this article on the social bookmarking site of your choice.

Read more about social bookmarking at Wikipedia - Social Bookmarking

Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2016 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.